wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30436996-2D44E021-3521-4216-B0D5-B8604CDA70CA
Q30436996-2D44E021-3521-4216-B0D5-B8604CDA70CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30436996-2D44E021-3521-4216-B0D5-B8604CDA70CA
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia.
P2860
Q30436996-2D44E021-3521-4216-B0D5-B8604CDA70CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30436996-2D44E021-3521-4216-B0D5-B8604CDA70CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
03ab6143b83afbc9251f266285c46f4bde2b6aba
P2860
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.